Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 15, Issue 3, 2003, Pages 375-377

  Takahashi, Hitoshi ^a   Higuchi, Hisashi ^b   Kamata, Mitsuhiro ^b   Naitoh, Shingo ^b   Yoshida, Keizo ^b   Shimizu, Tetsuo ^b   Sugita, Takio ^b  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; PROLACTIN; QUETIAPINE; RISPERIDONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; HUMAN; MENSTRUAL CYCLE; MENSTRUATION DISORDER; MENTAL DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0042161663     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.15.3.375     Document Type: Article

References (9)

1. Nordstrom AL, Farde L: Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients. J Clin Psychopharmacol 1998; 18:305-310
2. David SR, Taylor CC, Kinon BJ, et al: The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 2000; 22:1085-1096
3. Spark RF: Prolactin. In: Lavin N, ed. Manual of Endocrinology and Metabolism. 2nd ed. Little, Brown and Co, Boston 1994; pp. 97-103
4. Hamner MB, Arvanitis LA, Miller BG et al: Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636). Psychopharmacol Bull 1996; 32:107-110
5. Petty RG: Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999; 35 Suppl:S67-73
6. Emsley RA., Raniwalla J, Bailey PJ, et al: A comparison of the effects of quetiapine ('Seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. Int Clin Psychopharmacol 2000; 15:121-131
7. Kapur, S, Zipursky, R, Jones C, et al: A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 2000; 57:553-559
8. Kapur S, Remington G, Jones C, et al: High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 1996; 153:948-950
9. Kapur S, Seeman P: Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 2001; 158:360-369